Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.
Saved in:
| Title: | Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer. |
|---|---|
| Authors: | Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Tinè G; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Boige V; Department of Oncologic Medicine, Gustave-Roussy, Villejuif Cedex, France., Ballhausen A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany., Gourgou S; Biometrics Unit, Cancer Institute of Montpellier, Montpellier, France., Stahler A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany., Randon G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Manca P; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Brument E; UCGI, Prodige Intergroup, UNICANCER, Paris, France., Alig AHS; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany., Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Prisciandaro M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Ambrosini M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Fazio R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Zhu Y; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Miceli R; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Bouche O; Department of Digestive Oncology, CHU Reims, Reims, France., Modest DP; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany., Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2026 May 22. Date of Electronic Publication: 2026 May 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
